Pathology and genetics of phaeochromocytoma and paraganglioma

116Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

Abstract

Phaeochromocytoma and paraganglioma (PHEO/PGL) are rare tumours with an estimated annual incidence of 3 per million. Advances in molecular understanding have led to the recognition that at least 30–40% arise in the setting of hereditary disease. Germline mutations in the succinate dehydrogenase genes SDHA, SDHB, SDHC, SDHD and SDHAF2 are the most prevalent of the more than 19 hereditary genetic abnormalities which have been reported. It is therefore recommended that, depending on local resources and availability, at least some degree of genetic testing should be offered to all PHEO/PGL patients, including those with clinically sporadic disease. It is now accepted that that all PHEO/PGL have some metastatic potential; therefore, concepts of benign and malignant PHEO/PGL have no meaning and have been replaced by a risk stratification approach. Although there is broad acceptance that certain features, including high proliferative activity, invasive growth, increased cellularity, large tumour nests and comedonecrosis, are associated with an increased risk of metastasis, it remains difficult to predict the clinical behaviour of individual tumours and no single risk stratification scheme is endorsed or in widespread use. In this review, we provide an update on advances in the pathology and genetics of PHEO/PGL with an emphasis on the changes introduced in the WHO 2017 classification of endocrine neoplasia relevant to practising surgical pathologists.

References Powered by Scopus

Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline

1983Citations
N/AReaders
Get full text

Germ-line mutations in nonsyndromic pheochromocytoma

1233Citations
N/AReaders
Get full text

Genetic testing in pheochromocytoma or functional paraganglioma

595Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Pheochromocytoma and paraganglioma

413Citations
N/AReaders
Get full text

New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

181Citations
N/AReaders
Get full text

Schwann cell precursor: a neural crest cell in disguise?

115Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Turchini, J., Cheung, V. K. Y., Tischler, A. S., De Krijger, R. R., & Gill, A. J. (2018, January 1). Pathology and genetics of phaeochromocytoma and paraganglioma. Histopathology. Blackwell Publishing Ltd. https://doi.org/10.1111/his.13402

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

67%

Researcher 6

17%

Professor / Associate Prof. 3

8%

Lecturer / Post doc 3

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 26

63%

Biochemistry, Genetics and Molecular Bi... 12

29%

Agricultural and Biological Sciences 2

5%

Neuroscience 1

2%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 34

Save time finding and organizing research with Mendeley

Sign up for free